These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12488995)

  • 1. Systemic anticoagulation and bleeding in children with hemodialysis catheters.
    Moritz ML; Vats A; Ellis D
    Pediatr Nephrol; 2003 Jan; 18(1):68-70. PubMed ID: 12488995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ultra-low dose and standard heparin locks on early tunnelled dialysis catheter outcomes in low-risk dialysis patients.
    Renaud CJ; Lim EK; Tho SJ; Yeoh LY
    Nephrology (Carlton); 2015 Feb; 20(2):85-90. PubMed ID: 25346031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trisodium citrate: an alternative to unfractionated heparin for hemodialysis catheter dwells.
    Pierce DA; Rocco MV
    Pharmacotherapy; 2010 Nov; 30(11):1150-8. PubMed ID: 20973688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodialysis catheter heparin lock related bleeding: Hemorrhagic shock every other day.
    Marques J; Duarte TI; Cotovio P; Borges A; Germano N
    J Vasc Access; 2022 May; 23(3):455-457. PubMed ID: 33570006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.
    Weijmer MC; van den Dorpel MA; Van de Ven PJ; ter Wee PM; van Geelen JA; Groeneveld JO; van Jaarsveld BC; Koopmans MG; le Poole CY; Schrander-Van der Meer AM; Siegert CE; Stas KJ;
    J Am Soc Nephrol; 2005 Sep; 16(9):2769-77. PubMed ID: 16033861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heparin flush syndrome: a cause of iatrogenic hemorrhage.
    Passannante A; Macik BG
    Am J Med Sci; 1988 Jul; 296(1):71-3. PubMed ID: 3407682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
    Prescrire Int; 2009 Jun; 18(101):118. PubMed ID: 19637430
    [No Abstract]   [Full Text] [Related]  

  • 8. Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments.
    Davenport A
    Pediatr Nephrol; 2012 Oct; 27(10):1869-79. PubMed ID: 22374405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding.
    Pinnick RV; Wiegmann TB; Diederich DA
    N Engl J Med; 1983 Feb; 308(5):258-61. PubMed ID: 6848936
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of systemic anticoagulation in patients undergoing angioaccess surgery.
    D'Ayala M; Smith RM; Martone C; Briggs W; Deitch JS; Wise L
    Ann Vasc Surg; 2008 Jan; 22(1):11-5. PubMed ID: 18055171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inadvertent postdialysis anticoagulation due to heparin line locks.
    Pepper RJ; Gale DP; Wajed J; Bommayya G; Ashby D; McLean A; Laffan M; Maxwell PH
    Hemodial Int; 2007 Oct; 11(4):430-4. PubMed ID: 17922740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of heparins in end-stage renal disease.
    Sonawane S; Kasbekar N; Berns JS
    Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.
    Thomas CM; Zhang J; Lim TH; Scott-Douglas N; Hons RB; Hemmelgarn BR;
    ASAIO J; 2007; 53(4):485-8. PubMed ID: 17667236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial.
    Klenner AF; Fusch C; Rakow A; Kadow I; Beyersdorff E; Eichler P; Wander K; Lietz T; Greinacher A
    J Pediatr; 2003 Dec; 143(6):741-5. PubMed ID: 14657819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation during haemodialysis in patients at high-risk of bleeding.
    Kim YG
    Nephrology (Carlton); 2003 Oct; 8 Suppl():S23-7. PubMed ID: 15012687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review: anticoagulation for haemodialysis.
    Suranyi M; Chow JS
    Nephrology (Carlton); 2010 Jun; 15(4):386-92. PubMed ID: 20609088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical consequences of heparin-free hemodialysis.
    McGill RL; Blas A; Bialkin S; Sandroni SE; Marcus RJ
    Hemodial Int; 2005 Oct; 9(4):393-8. PubMed ID: 16219060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essentials of anticoagulation in hemodialysis.
    Fischer KG
    Hemodial Int; 2007 Apr; 11(2):178-89. PubMed ID: 17403168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.